5 Best CBD Stocks to Buy Right Now

3. Organigram Global Inc (NASDAQ:OGI)

Stock Upside Potential: 142.91%

Number of Hedge Fund Holders: 4

Organigram Global Inc (NASDAQ:OGI) is one of the best CBD stocks to buy right now. Analysts expect Organigram Global shares to explode by more than 140% over the next 12 months.

On May 12, Organigram Global Inc (NASDAQ:OGI) reported its March quarter results and issued guidance for 2026 revenue. The March quarter report showed net revenue declined 9% YoY to $59.8 million. Adjusted EBITDA of $0.9 million compared with $4.9 million a year ago.

The company said that weakness in its vapes business, infused pre-roll production challenges, and slower industry growth led to the quarterly declines. The company booked lower vape and pre-roll sales in the latest quarter than it did a year ago.

Organigram CEO James Yamanaka said they acted quickly to address these issues. As a result, product enhancements and operational adjustments that the company implemented are stabilizing performance. The company also expects the improvement in yields and flower potency as well as the contribution from Sanity Group to drive performance improvement in the second half of 2026.

Sanity is a Germany-based cannabis company that Organigram acquired at the end of the March quarter. Sanity has a diversified cannabis business and expanding operations across Europe, including footprints in the UK, Poland, Switzerland, and Czechia. Organigram expects Sanity to generate roughly €25 million in quarterly revenue over the next year. In light of the expected Sanity contribution, Organigram raised its 2026 revenue outlook to $350 million from the previous $300 million.

Organigram Global Inc (NASDAQ:OGI) is a Canadian company that grows cannabis and manufactures a variety of cannabis-derived products for recreational and wellness use. Its product range includes CBD-infused edibles under the Monjour brand.

1281292 - 11759070 - 1